These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18928414)

  • 21. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
    Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.
    Potenza MN; Holmes JP; Kanes SJ; McDougle CJ
    J Clin Psychopharmacol; 1999 Feb; 19(1):37-44. PubMed ID: 9934941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
    Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label olanzapine treatment in five preadolescent children.
    Krishnamoorthy J; King BH
    J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavioral disorders.
    Handen BL; Hardan AY
    J Am Acad Child Adolesc Psychiatry; 2006 Aug; 45(8):928-935. PubMed ID: 16865035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit/hyperactivity disorder and persistent, serious conduct problems.
    Stocks JD; Taneja BK; Baroldi P; Findling RL
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):102-11. PubMed ID: 22372512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
    Ercan ES; Uysal T; Ercan E; Akyol Ardic U
    Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia.
    Alvarez E; Ciudad A; Olivares JM; Bousoño M; Gómez JC
    J Clin Psychopharmacol; 2006 Jun; 26(3):238-49. PubMed ID: 16702888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW; Earl CQ; Arora S
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label study of olanzapine in children and adolescents with schizophrenia.
    Quintana H; Wilson MS; Purnell W; Layman AK; Mercante D
    J Psychiatr Pract; 2007 Mar; 13(2):86-96. PubMed ID: 17414684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine in Gilles de la Tourette syndrome: beyond tics.
    Van den Eynde F; Naudts KH; De Saedeleer S; van Heeringen C; Audenaert K
    Acta Neurol Belg; 2005 Dec; 105(4):206-11. PubMed ID: 16482870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder.
    Ho CS; Chen HJ; Chiu NC; Shen EY; Lue HC
    J Formos Med Assoc; 2009 Oct; 108(10):788-93. PubMed ID: 19864199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.